15 Leading Single-Use Bioreactors Companies Shaping Innovation and Market Growth to 2031

Discover the top 15 companies driving innovation in the single-use bioreactors market. This in-depth analysis explores competitive advantages, transformative trends, and key players poised to influence biopharmaceutical manufacturing, monoclonal antibody production, vaccine development, and cell and gene therapy manufacturing through 2031. Single-Use Bioreactors Market by Product [System (By Scale), Bags (2D, 3D), Assemblies], Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031 report for further insights.

Spotlights on the Industry's Top Single-Use Bioreactors Companies

The single-use bioreactors market is evolving as biopharmaceutical manufacturers adopt flexible, scalable production technologies for biologics, vaccines, and advanced therapies. Disposable bioreactor systems use single-use bags and fluid-contact components to reduce cleaning and sterilization requirements, support faster manufacturing changeovers, and help minimize cross-contamination risks. Advances in stirred-tank designs, process monitoring, automation, sensor integration, and disposable fluid management are expanding adoption across research, clinical development, and commercial manufacturing. Competition centers on scalability, process control, material compatibility, extractables and leachables management, supply-chain reliability, and integration with upstream and downstream bioprocessing operations. Leading suppliers are strengthening their portfolios through complete bioreactor systems, sterile assemblies, single-use bags, tubing, connectors, and complementary process technologies.

1. Sartorius AG

Sartorius AG is a major supplier of bioprocessing technologies, including single-use bioreactor systems, disposable bags, and fluid management solutions for biopharmaceutical manufacturing. Its BIOSTAT STR stirred-tank systems support scalable cell culture processes, including applications involving mammalian cells and biologics production. The company also offers complementary filtration, separation, and process monitoring technologies that help manufacturers establish integrated workflows. Sartorius combines bioreactor engineering, disposable components, and process expertise to support production from process development through commercial manufacturing, making it a significant participant in the single-use bioprocessing market.

2. Danaher Corporation

Danaher Corporation participates in the single-use bioreactor market through its life sciences and bioprocessing businesses, including Cytiva. Cytiva's portfolio includes Xcellerex single-use bioreactor systems, disposable bioprocess containers, tubing, connectors, and other fluid management components. These technologies support upstream cell culture and biopharmaceutical manufacturing across different production scales. Danaher's broader capabilities in filtration, chromatography, process analytics, and automation complement its disposable bioreactor offerings. This integrated portfolio helps biopharmaceutical manufacturers connect upstream production with downstream purification and process control while improving flexibility across development and commercial operations.

3. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. offers single-use bioreactor systems and related bioprocessing products through its bioproduction portfolio. Its HyPerforma single-use bioreactors, including stirred-tank configurations, support cell culture and biologics production across development and manufacturing scales. The company also supplies single-use bioprocess containers, media, reagents, and complementary technologies used in upstream manufacturing workflows. By combining disposable systems with laboratory products and biopharmaceutical manufacturing services, Thermo Fisher supports organizations seeking scalable and integrated production processes. Its global manufacturing and distribution capabilities are relevant to biologics, vaccine development, and other advanced biopharmaceutical applications.

4. Merck KGaA

Merck KGaA, known as MilliporeSigma in the United States and Canada, supplies single-use bioprocessing technologies for pharmaceutical and biotechnology manufacturers. Its Mobius portfolio includes single-use assemblies, process containers, tubing, connectors, and other disposable components used in biopharmaceutical production. These products support fluid transfer, media preparation, process handling, and sterile manufacturing workflows associated with biologics and vaccines. Merck also provides filtration, purification, and process development solutions that complement upstream bioreactor operations. Its broad bioprocessing portfolio helps manufacturers develop integrated disposable workflows while addressing process consistency, sterility, and operational efficiency.

5. Avantor, Inc.

Avantor, Inc. supplies high-purity materials, laboratory products, and biopharmaceutical manufacturing solutions that support single-use bioprocessing operations. Its portfolio includes process chemicals, buffers, cell culture-related materials, and specialized products used in biologics manufacturing. Avantor also provides fluid management and single-use technologies through its biopharmaceutical supply offerings, helping manufacturers source materials and components for controlled production environments. Its relevance to the single-use bioreactor market lies in supplying complementary process inputs and bioprocessing solutions rather than relying exclusively on standalone bioreactor systems. Material quality and supply-chain consistency are important considerations for its customers.

6. Repligen Corporation

Repligen Corporation develops technologies for bioprocessing, including single-use fluid management components, filtration products, and solutions that support upstream and downstream manufacturing. Its portfolio includes XCell ATF systems for cell culture intensification, along with tubing, connectors, and other disposable flow-path components used in biopharmaceutical production. These technologies can complement single-use bioreactors by supporting cell retention, perfusion, and efficient process operation. Repligen's focus on specialized bioprocess technologies makes it relevant to manufacturers seeking to improve productivity and process flexibility in biologics production, particularly where intensified cell culture strategies are used.

7. Getinge AB

Getinge AB provides equipment and solutions for pharmaceutical production, sterile processing, and biopharmaceutical manufacturing. Its life sciences portfolio includes technologies used in pharmaceutical facilities, such as sterilization systems and equipment supporting controlled production environments. These capabilities can complement single-use bioreactor installations by supporting facility operations and contamination-control strategies. However, Getinge's core portfolio is not centered on disposable stirred-tank bioreactor systems or single-use bioreactor bags. Its relevance is therefore strongest in the broader biopharmaceutical manufacturing ecosystem, and its classification as a direct single-use bioreactor supplier should be reviewed against the specific market scope.

8. Eppendorf SE

Eppendorf SE develops laboratory equipment and bioprocessing technologies used in life sciences research and biopharmaceutical development. Its bioprocess portfolio includes BioBLU single-use bioreactor vessels designed for use with compatible Eppendorf control systems. These vessels support cell culture and microbial applications across laboratory-scale process development and optimization. Eppendorf also supplies benchtop bioreactors, control technologies, and laboratory consumables that help researchers establish and evaluate production processes before scale-up. Its expertise in bioprocess control and single-use vessels makes it relevant to research organizations and biopharmaceutical manufacturers developing reproducible and scalable upstream workflows.

9. Parker Hannifin Corporation

Parker Hannifin Corporation supplies motion and control technologies, filtration products, fluid connectors, and engineered components used across industrial and life sciences applications. Its biopharmaceutical-related offerings include fluid management technologies and components that can support disposable processing assemblies and controlled fluid transfer. Reliable tubing connections, filtration, and fluid handling are important in single-use bioreactor systems, where maintaining sterile process boundaries is essential. Parker's relevance lies primarily in complementary fluid management and process components rather than a broad portfolio of complete single-use bioreactor systems. Product suitability depends on material compatibility and qualification for the intended biopharmaceutical process.

10. Entegris

Entegris provides advanced materials, filtration, purification, and fluid handling solutions for high-purity manufacturing applications, including selected life sciences and biopharmaceutical processes. Its technologies can support the management of process fluids and contamination control in manufacturing environments where product quality is critical. Within single-use bioprocessing, relevant components must meet demanding requirements for chemical compatibility, cleanliness, and process integrity. Entegris is more closely associated with specialized materials and fluid management technologies than with complete single-use bioreactor systems. Its relevance to this market should be evaluated according to the specific disposable bioprocess products available for the intended application.

11. Saint-Gobain

Saint-Gobain supplies engineered materials and fluid management products used in pharmaceutical, biotechnology, and industrial applications. Its life sciences-related portfolio includes tubing and other fluid-contact components that can be incorporated into bioprocessing assemblies. In single-use bioreactor workflows, these products support the transfer of media, buffers, and process fluids while helping manufacturers address requirements for chemical compatibility and product integrity. Saint-Gobain's expertise in polymer materials and engineered components makes it relevant to the wider disposable bioprocessing supply chain. Its role is primarily associated with materials and fluid handling rather than complete bioreactor systems.

12. Corning Incorporated

Corning Incorporated supplies laboratory products and bioprocessing technologies used in cell culture, biologics development, and pharmaceutical manufacturing. Its product portfolio includes the Xcellerex single-use bioreactor business, acquired through its acquisition of the bioprocess equipment business from Cytiva, alongside cell culture vessels and related technologies. Its single-use bioreactor systems support scalable cell culture operations, while its broader expertise in cell culture surfaces and laboratory materials complements upstream process development. Corning's combination of bioprocess equipment and laboratory technologies makes it relevant to manufacturers developing and scaling production workflows for biologics and other cell-based products.

13. Lonza

Lonza is a major contract development and manufacturing organization (CDMO) serving pharmaceutical, biotechnology, and advanced therapy companies. Its manufacturing operations use bioreactor technologies and disposable processing systems to support the production of biologics and other complex therapies. Lonza's expertise spans process development, cell culture, manufacturing scale-up, and commercial production, making single-use technologies relevant to its flexible manufacturing capabilities. The company should be distinguished primarily as a bioprocessing services and manufacturing provider rather than assumed to be a major supplier of standalone commercial single-use bioreactor equipment. Its role is particularly relevant to customers outsourcing biologics production.

14. Tecnic Process Equipment Manufacturing, S.L.

Tecnic Process Equipment Manufacturing, S.L. specializes in process equipment and engineering solutions for pharmaceutical, biotechnology, and related industries. Its potential relevance to single-use bioreactors depends on the specific systems and disposable technologies it supplies, including any offerings for bioprocess vessels, fluid handling, or process integration. Equipment engineering and manufacturing capabilities can support the development of customized production workflows, but these capabilities alone do not establish a broad position in the single-use bioreactor market. The company's current product range and direct involvement in disposable bioreactor systems should be verified before making more specific claims about its competitive role.

15. Zacros Corporation

Zacros Corporation develops packaging materials and polymer-based products, including multilayer film technologies for applications requiring specific barrier and material performance characteristics. Flexible films are important in biopharmaceutical manufacturing, where single-use bags and containers must maintain product protection and process integrity. However, packaging film expertise does not automatically establish participation in the supply of qualified single-use bioreactor bags or complete bioprocess assemblies. Zacros's direct relevance depends on whether its current portfolio includes materials specifically developed and validated for biopharmaceutical fluid-contact applications. Its inclusion as a leading single-use bioreactor supplier should therefore be confirmed against the report's defined competitive landscape.